Cañete, Al-jadid S.

HRN: 20-50-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2022
10/19/2022
IVT
80mg
Q8hrs
Amoebiasis
Waiting Final Action 
10/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/13/2022
10/20/2022
IV
190mg
Q6hours
PCAP-B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: